Ethics of diabetic drugs for weight loss in hidradenitis suppurativa patients

J Am Acad Dermatol. 2023 Aug 7:S0190-9622(23)02421-0. doi: 10.1016/j.jaad.2023.07.1028. Online ahead of print.

Authors

Maria Katsetos¹, Kristin Torre², Jane M Grant-Kels³

Affiliations

¹ University of Connecticut School of Medicine, Farmington, Connecticut.
² Department of Dermatology, University of Connecticut Health, Farmington, Connecticut.
³ Department of Dermatology, University of Connecticut Health, Farmington, Connecticut; Department of Dermatology, University of Florida, Gainesville, Florida. Electronic address: grant@uchc.edu.

PMID: 37558092
DOI: 10.1016/j.jaad.2023.07.1028

No abstract available

Keywords: diabetes; ethics; hidradenitis suppurativa; justice; maleficence; medication shortages; semaglutide; weight loss.

Publication types

Letter